Wuhan Hvsen Biotechnology Co Ltd (300871) — Free Cash Flow Generation Index
Wuhan Hvsen Biotechnology Co Ltd (300871) has a Free Cash Flow Generation Index of 0.68x as of September 2025. Free cash flow of CN¥40.33 Million represents 1% of operating cash flow (CN¥59.06 Million). Read 300871 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Wuhan Hvsen Biotechnology Co Ltd Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Wuhan Hvsen Biotechnology Co Ltd across 10 annual periods. Explore 300871 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Wuhan Hvsen Biotechnology Co Ltd (2016–2025)
Year-by-year Free Cash Flow Generation Index for Wuhan Hvsen Biotechnology Co Ltd. For the full company profile including market capitalisation, see 300871 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | CN¥141.53 Million | CN¥238.45 Million | CN¥96.92 Million | ▲ +117.1% |
| 2024 | -3.47x | CN¥-150.89 Million | CN¥43.53 Million | CN¥194.43 Million | ▼ -252.4% |
| 2023 | -0.98x | CN¥-91.39 Million | CN¥92.92 Million | CN¥184.31 Million | ▲ +71.4% |
| 2022 | -3.44x | CN¥-332.18 Million | CN¥96.68 Million | CN¥428.87 Million | ▼ -20.4% |
| 2021 | -2.85x | CN¥-444.40 Million | CN¥155.72 Million | CN¥600.12 Million | ▲ +24.4% |
| 2020 | -3.77x | CN¥-182.49 Million | CN¥48.35 Million | CN¥230.84 Million | ▼ -2129.4% |
| 2019 | -0.17x | CN¥-17.82 Million | CN¥105.24 Million | CN¥123.06 Million | ▲ +72.4% |
| 2018 | -0.61x | CN¥-12.96 Million | CN¥21.10 Million | CN¥34.05 Million | ▼ -304.8% |
| 2017 | 0.30x | CN¥24.16 Million | CN¥80.56 Million | CN¥56.40 Million | ▼ -43.8% |
| 2016 | 0.53x | CN¥32.03 Million | CN¥60.00 Million | CN¥27.97 Million | — |